IVERMECTIN – Articles and Protocols for CANCER from Dr. William Makis

by Val | Jul 7, 2024

From Dr. Makis’s X account:

Did you know that Ivermectin is annually taken by close to 250 million people?

Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones:

1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt)

2. Inhibits Cancer Stem Cells

IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo)

Here are recent studies on IVERMECTIN use in certain types of cancer:

BLADDER CANCER – (2024 Fan et al) – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage

LUNG CANCER – (2024 Man-Yuan Li et al) – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells

GLIOMA – (2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma

MULTIPLE MYELOMA – (2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma

OVARIAN CANCER – (2023 Jawad et al) – Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells

PROSTATE CANCER – (2022 Lu et al) – Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer

COLON CANCER – (2022, Alghamdi et al) – Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats

PANCREATIC CANCER – (2022 Lee et al) – Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction

MELANOMA – (2022 Zhang et al) – Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis

2024 – NEW STUDIES!

(2024 Fan et al) – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage
(2024 Man-Yuan Li et al) – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
(2024 Kaur et al) – Ivermectin: A Multifaceted drug with a potential beyond anti-parasitic therapy
(2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma
(2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
(2024 Goldfarb et al) – Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell Sensitivities
(2024 Newell et al) – Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy

IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap.

Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines.

IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. That’s how it should be.